The burden of male breast cancer (MBC) in the GBD Central, Eastern, and Western Europe Regions from 1990 to 2023: Results from the Global Burden of Disease Study 2023

Evolving burden of pancreatic cancer in the Middle East and North Africa Region, 1990–2023: an analysis based on the Global Burden of Disease Study 2023

The rapidly increasing burden of pancreatic cancer in the MENA region, largely driven by metabolic risk factors and an aging population, necessitates targeted public health strategies.

Using the

Global burden of skin cancers and trends from 1990 to 2021: An observational study based on secondary analysis of GBD 2021

The study indicates that skin cancer remains an important public health issue worldwide and countries and regions should attach great importance to the prevention and treatment of skin cancers, and develop and improve preventive measures.

Global Dual Incidence‐Mortality Patterns of Prostate Cancer Across SDI Regions, 1990–2021: A Cross‐Sectional Study Based on Global Burden of Disease 2021

This research offers a comprehensive evaluation of the global prostate cancer landscape, with a specific focus on its incidence, mortality rates, and underlying risk factors.

Prognostic impact of time from diagnosis to start of radiotherapy in anal cancer

Investigation of the impact of TTRT on overall survival (OS) and anal cancer‐specific survival (ACSS) in a nationwide population‐based cohort from the Swedish Anal Cancer Registry finds no change in survival.

Burden of Mesothelioma in China, 1990–2023: Trends, Decomposition, and Projections Until 2045

From 1990 to 2023, China’s mesothelioma burden rose sharply, with cases up 189% and deaths up 142%, mainly affecting older males, mainly affecting older males.